Literature DB >> 4652612

Growth and development of larval Taenia crassiceps (cestoda). I. Aneuploidy in the anomalous ORF strain.

J K Smith, G W Esch, R E Kuhn.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4652612     DOI： 10.1016/0020-7519(72)90014-8

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN： 0020-7519            Impact factor:   3.981


× No keyword cloud information.
  8 in total

1.  Murine Taenia crassiceps cysticercosis: H-2 complex and sex influence on susceptibility.

Authors:  E Sciutto; G Fragoso; M L Diaz; F Valdez; R M Montoya; T Govezensky; C Lomeli; C Larralde
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  The Genomes of Two Strains of Taenia crassiceps the Animal Model for the Study of Human Cysticercosis.

Authors:  Raúl J Bobes; Karel Estrada; Diana G Rios-Valencia; Arturo Calderón-Gallegos; Patricia de la Torre; Julio C Carrero; Alejandro Sanchez-Flores; Juan P Laclette
Journal:  Front Cell Infect Microbiol       Date:  2022-05-10       Impact factor: 6.073

3.  Gender-associated differential expression of cytokines in specific areas of the brain during helminth infection.

Authors:  Lorena López-Griego; Karen Elizabeth Nava-Castro; Valeria López-Salazar; Rosalía Hernández-Cervantes; Nelly Tiempos Guzmán; Saé Muñiz-Hernández; Romel Hernández-Bello; Hugo O Besedovsky; Lenin Pavón; Luis Enrique Becerril Villanueva; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-12-11       Impact factor: 2.607

4.  Budding of Taenia crassiceps cysticerci in vitro is promoted by crowding in addition to hormonal, stress, and energy-related signals.

Authors:  Pedro Ostoa-Saloma; Pedro Ostoa-Jacobo; Marcela Esquivel-Velázquez; Silvana Bazúa; Carlos Larralde
Journal:  J Biomed Biotechnol       Date:  2010-01-20

5.  Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine.

Authors:  Dunia Rassy; Raúl J Bobes; Gabriela Rosas; Victor H Anaya; Klaus Brehm; Beatriz Hernández; Jacquelynne Cervantes; Saúl Pedraza; Julio Morales; Nelly Villalobos; Aline S de Aluja; Juan P Laclette; Caris M Nunes; Germano F Biondi; Gladis Fragoso; Marisela Hernández; Edda Sciutto
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

6.  Antigens from Taenia crassiceps cysticerci used in complement fixation, enzyme-linked immunosorbent assay, and western blot (immunoblot) for diagnosis of neurocysticercosis.

Authors:  E Garcia; G Ordoñez; J Sotelo
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection.

Authors:  E Sciutto; G Fragoso; M Baca; V De la Cruz; L Lemus; E Lamoyi
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 8.  Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine.

Authors:  M W Lightowlers
Journal:  Parasite Immunol       Date:  2010 Nov-Dec       Impact factor: 2.280
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.